ScreenIT
The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
Evaluation of SARS-CoV-2 antibody point of care devices in the laboratory and clinical setting
This article has 14 authors:Reviewed by ScreenIT
-
Social mixing patterns relevant to infectious diseases spread by close contact in urban Blantyre, Malawi
This article has 13 authors:Reviewed by ScreenIT
-
Aerosol decontamination and spatial separation using a free-space LED-based UV-C light curtain
This article has 7 authors:Reviewed by ScreenIT
-
Potential severity, mitigation, and control of Omicron waves depending on pre-existing immunity and immune evasion
This article has 6 authors:Reviewed by ScreenIT
-
COVID-19 vaccination, from first dose to booster: New insights into the frequency of most common systemic adverse events and possible booster nocebo effects based on a systematic review
This article has 6 authors:Reviewed by ScreenIT
-
Projected epidemiological consequences of the Omicron SARS-CoV-2 variant in England, December 2021 to April 2022
This article has 5 authors:Reviewed by ScreenIT
-
Breakthrough SARS-CoV-2 infections in double and triple vaccinated adults and single dose vaccine effectiveness among children in Autumn 2021 in England: REACT-1 study
This article has 20 authors:Reviewed by ScreenIT
-
Change in long‐term care service usage in Japan following the COVID ‐19 pandemic: A survey using a nationwide statistical summary in 2018–2021
This article has 4 authors:Reviewed by ScreenIT
-
Comparison of the immunogenicity of five COVID‐19 vaccines in Sri Lanka
This article has 25 authors:Reviewed by ScreenIT
-
Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England
This article has 12 authors:Reviewed by ScreenIT